Joo Mi Yi

3.0k total citations
79 papers, 2.0k citations indexed

About

Joo Mi Yi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Joo Mi Yi has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 19 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Joo Mi Yi's work include Epigenetics and DNA Methylation (42 papers), RNA modifications and cancer (15 papers) and Cancer Cells and Metastasis (10 papers). Joo Mi Yi is often cited by papers focused on Epigenetics and DNA Methylation (42 papers), RNA modifications and cancer (15 papers) and Cancer Cells and Metastasis (10 papers). Joo Mi Yi collaborates with scholars based in South Korea, United States and Japan. Joo Mi Yi's co-authors include Mei Jing Piao, Jin Won Hyun, Kyoung Ah Kang, Mee Jung Ahn, Kwangmo Yang, Nita Ahuja, Ao Xuan Zhen, Tae Oh Kim, James G. Herman and Stephen B. Baylin and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Joo Mi Yi

78 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joo Mi Yi South Korea	26	1.3k	488	459	202	188	79	2.0k
Rudolf B. Beems Netherlands	24	1.3k 1.0×	539 1.1×	481 1.0×	73 0.4×	224 1.2×	64	2.0k
Rodney E. Shackelford United States	25	1.2k 0.9×	504 1.0×	428 0.9×	272 1.3×	65 0.3×	62	2.1k
Aaron D. Tward United States	23	1.6k 1.3×	762 1.6×	631 1.4×	228 1.1×	64 0.3×	40	3.4k
Lisiane B. Meira United States	31	2.0k 1.5×	653 1.3×	648 1.4×	92 0.5×	66 0.4×	61	2.6k
S. Nishimura Japan	13	1.4k 1.1×	681 1.4×	213 0.5×	91 0.5×	133 0.7×	23	2.0k
David Gilot France	25	1.0k 0.8×	347 0.7×	307 0.7×	86 0.4×	303 1.6×	54	2.2k
Erika Rosivatz United Kingdom	18	1.1k 0.8×	317 0.6×	616 1.3×	172 0.9×	246 1.3×	25	1.8k
Michael H.L. Green United Kingdom	28	1.0k 0.8×	460 0.9×	157 0.3×	72 0.4×	114 0.6×	56	1.8k
David M. Nelson United States	24	2.0k 1.5×	211 0.4×	466 1.0×	85 0.4×	69 0.4×	45	2.9k
Tsung‐Yun Liu Taiwan	24	880 0.7×	565 1.2×	314 0.7×	143 0.7×	99 0.5×	55	1.8k

Countries citing papers authored by Joo Mi Yi

Since Specialization

Citations

This map shows the geographic impact of Joo Mi Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joo Mi Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joo Mi Yi more than expected).

Fields of papers citing papers by Joo Mi Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joo Mi Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joo Mi Yi. The network helps show where Joo Mi Yi may publish in the future.

Co-authorship network of co-authors of Joo Mi Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Joo Mi Yi. A scholar is included among the top collaborators of Joo Mi Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joo Mi Yi. Joo Mi Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Seungmo, Tae Sung Kim, Eun Ji Lee, et al.. (2025). Colony-stimulating factor 3 as a key mediator in the progression of idiopathic pulmonary fibrosis: a novel therapeutic target. Signal Transduction and Targeted Therapy. 10(1). 322–322.

Masood, Ashiq, et al.. (2025). LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in BRAF mutant colorectal cancer. Molecular Cancer. 24(1). 122–122. 2 indexed citations

Yi, Joo Mi. (2024). Epigenetic regulation of HERVs: Implications for cancer immunotherapy. Genes & Genomics. 46(11). 1303–1312. 2 indexed citations

Uddin, Nizam, Seungmo Kim, Yi Zhao, et al.. (2024). Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR. Molecular Cancer. 23(1). 230–230. 14 indexed citations

Kim, Jung Min, Hongseok Ha, Joo Mi Yi, et al.. (2023). Human Endogenous Retrovirus-H-Derived miR-4454 Inhibits the Expression of DNAJB4 and SASH1 in Non-Muscle-Invasive Bladder Cancer. Genes. 14(7). 1410–1410. 6 indexed citations

Choi, Jae Yeon, et al.. (2023). Targeting miR-5088-5p attenuates radioresistance by suppressing Slug. Non-coding RNA Research. 8(2). 164–173. 5 indexed citations

Choi, Jae Yeon, et al.. (2023). miR-765 as a promising biomarker for low-dose radiation-induced pulmonary fibrosis. Non-coding RNA Research. 9(1). 33–43. 2 indexed citations

Yi, Joo Mi, Tae‐Hong Kang, Yu Han, et al.. (2023). Human Neuralized is a novel tumour suppressor targeting Wnt/β‐catenin signalling in colon cancer. EMBO Reports. 24(8). e56335–e56335. 5 indexed citations

Yi, Joo Mi, et al.. (2023). Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice. Experimental & Molecular Medicine. 55(4). 767–778. 40 indexed citations

10.

Kim, Yeon-Ju, Yi Zhao, Jae Kyung Myung, et al.. (2021). Suppression of breast cancer progression by FBXL16 via oxygen-independent regulation of HIF1α stability. Cell Reports. 37(8). 109996–109996. 22 indexed citations

11.

Kim, Tae Oh, Yu Han, & Joo Mi Yi. (2020). Hypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients. Intestinal Research. 18(3). 297–305. 13 indexed citations

12.

Fernando, Pincha Devage Sameera Madushan, Mei Jing Piao, Ao Xuan Zhen, et al.. (2020). Extract of Cornus officinalis Protects Keratinocytes from Particulate Matter-induced Oxidative Stress. International Journal of Medical Sciences. 17(1). 63–70. 29 indexed citations

13.

Kim, Young Kyun, Seung Hyeon Kim, Joo Mi Yi, et al.. (2017). Genetic identification and evolutionary trends of the seagrass Halophila nipponica in temperate coastal waters of Korea. PLoS ONE. 12(5). e0177772–e0177772. 12 indexed citations

14.

Vlodrop, Iris J.H. van, Sophie C. Joosten, Tim De Meyer, et al.. (2016). A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. Clinical Cancer Research. 23(8). 2006–2018. 44 indexed citations

15.

Park, So‐Hyun, et al.. (2015). Stem cell-like gene expression signature identified in ionizing radiation-treated cancer cells. Gene. 572(2). 285–291. 8 indexed citations

16.

Melotte, Veerle, Joo Mi Yi, Marjolein H.F.M. Lentjes, et al.. (2014). Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood. Cancer Prevention Research. 8(2). 157–164. 31 indexed citations

17.

Yi, Joo Mi, Angela A. Guzzetta, Vasudev J. Bailey, et al.. (2013). Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer. Clinical Cancer Research. 19(23). 6544–6555. 118 indexed citations

18.

Yi, Joo Mi, Mashaal Dhir, Leander Van Neste, et al.. (2011). Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer. Clinical Cancer Research. 17(6). 1535–1545. 118 indexed citations

19.

Yi, Joo Mi, Hsing-Chen Tsai, Sabine C. Glöckner, et al.. (2008). Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors. Cancer Research. 68(19). 8094–8103. 115 indexed citations

20.

Yi, Joo Mi, Osamu Takenaka, & Heui‐Soo Kim. (2005). Molecular cloning and phylogeny of HERV-E family that is expressed in Japanese monkey (Macaca fuscata) tissues. Archives of Virology. 150(5). 869–882. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact